Now accepting applications for our fall programs:
Application deadline is 9/8/17
Application deadline is 9/15/17
|
Aspire Participants Lead the Way
|
By Dot Lucci, M.Ed.CAGS and Miriam Zisook, B.F.A.
In the May issue of Aspire Wire, Dot wrote about STEM (science, technology, engineering and math) at Aspire and our Design Challenge Group that was co-led with Miriam Zisook. The Design Challenge group taught participants the "user-centered design" engineering process that would be used at the Chatter event on June 9-10, 2017.
Chatter stands for Collaboration Highlighting Autism Through Technology for Emotion and Relationships and was the cumulating event of the Design Challenge Group.
Research and development of technology to support the Autistic community is all too often done without Autistic involvement. This event took a different approach.
Read more
|
College Boot Camp: Apply by July 26th
|
College Boot Camp is designed for high school juniors and seniors, students doing a gap year and students making a transition back to college.
In this
one-week
summer program, participants learn about campus life,
how to connect with peers, how to decode a syllabus, and more. Click here to check out our YouTube video.
Application deadline is July 26, 2017.
Dates: Monday August 7 - Friday August 11
Time:
9:30 AM - 3:30 PM
Location: Lesley University
For more info on this program:
|
Making New Friends with Furry Creatures
|
This month our youngest Aspire campers at Hale Reservation had the chance to learn about and hold baby bunnies, chicks, Lulu the pig, baby goats, and more! Cuteness was plentiful, as well as learning about the animals.
|
|
|
Lurie Center for Autism
The Lurie Center for Autism at Massachusetts General Hospital for Children is looking for participants for their currently enrolling studies. For additional information about study requirements and study procedures, please contact Dr. Christopher McDougle's or
Dr. Ann Neumeyer's
study staff at 781-860-1711 or
LurieCenterResearch@partners.org
.
Have a look at the research opportunities we currently have available:
- Children's Autism Metabolome Project (CAMP) - The Lurie Center is enrolling children ages 18 to 48 months who are in the process of getting evaluated for an autism spectrum disorder or developmental disorder, as well as typically developing children. This research study is being conducted to find out if a specific blood test is effective in the early detection of autism spectrum disorder. Participants are compensated for their time.
- Investigation of Neuroinflammation in Autism - Seeking men aged 18-40 years with and without autism to participate in an investigation of the structure and function of the brain of adults with and without autism using MR-PET scans. Participants are compensated for their time.
The Bressler Clinical and Research Center
-
ASD Namenda Study Taking Place at MGH -
This 12-week study seeks to evaluate the safety and efficacy of Namenda (memantine) for the treatment of core features of Autism Spectrum Disorder (ASD) in children and adolescents. Deficits in social interaction are the central feature of ASD and often result in significant impairment for individuals with High Functioning-ASD. Available data from past treatment studies of Namenda demonstrates improvements in a range of impairments including attentional and social skills in individuals with ASD. Eligible subjects, children ages 8-17 with a DSM-V diagnosis of ASD, will be enrolled to receive either placebo or Namenda. Subjects also complete a pre- and post-treatment brain scan before and after treatment with Namenda.
For more info, contact Abigail Belser: 781-724-7079 | abelser@partners.org
|
|
| |
|
Aspire
Internship Program
|
| About Aspire
Aspire is dedicated to providing children, teens, and adults with a high cognitive autism spectrum disorder or a related profile with the knowledge and skills necessary to make social connections and develop independence leading to successful and fulfilling lives.
MGH Aspire
1 Maguire Road
Lexington, MA 02421
p:781-860-1900
f: 781-860-1920
|
|
|
